Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Annette B. Beiderbeck"'
Autor:
Susan A. Oliveria, Arti Hurria, Cary P. Gross, Annette B. Beiderbeck, Marianne Ulcickas Yood, Karen Wells, Sharon Hensley Alford, Heather Dakki
Publikováno v:
Pharmacoepidemiology and Drug Safety. 21:818-827
Purpose Quantify incidence of cardiovascular outcomes in patients with advanced breast cancer receiving cardiotoxic and non-cardiotoxic chemotherapy.
Autor:
Paul D. van der Linden, NS Breekveldt-Postma, Annette B. Beiderbeck, JA Erkens, Jan Willem Coebergh, Myrthe P. P. Sukel, Ron M. C. Herings
Publikováno v:
Pharmacoepidemiology and Drug Safety. 17:125-134
Purpose To assess the incidence of cardiovascular events among breast cancer patients after chemotherapy. Methods Women ≥18 years with a breast tumour who received chemotherapy in 1992–2003 were selected from the PHARMO RLS. Chemotherapy with ant
Autor:
Antoine C. G. Egberts, Matthijs R. Graaf, Annette B. Beiderbeck, Dick J. Richel, Henk-Jan Guchelaar
Publikováno v:
Journal of clinical oncology, 22(12), 2388-2394. American Society of Clinical Oncology
Purpose Several preclinical studies suggested a role for 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors (statins) in the treatment of cancer. The objective of this study was to compare the risk of incident cancer between users of statins
Autor:
Hubert G. M. Leufkens, Annette B. Beiderbeck, Miriam C. J. M. Sturkenboom, Bruno H. Ch. Stricker, Jan W. Coebergh
Publikováno v:
Journal of Clinical Epidemiology, 57, 973-977. Elsevier Inc.
Background and objective In many observational studies, the association between drugs and disease is analyzed with information from a baseline interview. We investigated the magnitude and direction of exposure misclassification by comparing interview
Autor:
Annette B. Beiderbeck, Elizabeth A. Holly, Bruno H. Stricker, Jan W. Coebergh, Hubert G. M. Leufkens, Miriam C. J. M. Sturkenboom
Publikováno v:
Cancer Causes and Control. 14:639-644
Objective: Earlier studies with data on drug use from interview suggested that corticosteroids, estrogens and psychotropics may increase the risk of non-Hodgkin's lymphoma (NHL). The objective of this case–control study with complete pharmacy recor
Publikováno v:
Pharmacoepidemiology and Drug Safety. 18:1247-1249
Autor:
Marianne Ulcickas, Yood, Karen E, Wells, Sharon Hensley, Alford, Heather, Dakki, Annette B, Beiderbeck, Arti, Hurria, Cary P, Gross, Susan A, Oliveria
Publikováno v:
Pharmacoepidemiology and drug safety. 21(8)
To quantify incidence of cardiovascular outcomes in patients with advanced breast cancer receiving cardiotoxic and non-cardiotoxic chemotherapy.This study identified all women at a Midwestern health system with initial diagnosis of American Joint Com
Autor:
Steffen Christensen, Miriam Grijota, Annette B. Beiderbeck, Henrik Toft Sørensen, Lars Pedersen, Jette Brommann Kornum, Pia Wogelius
Publikováno v:
BMC Pulmonary Medicine, Vol 8, Iss 1, p 24 (2008)
BMC Pulmonary Medicine
Kornum, J, Christensen, S, Grijota, M, Pedersen, L, Wogelius, P, Beiderbeck, A & Sørensen, H T 2008, ' The incidence of interstitial lung disease 1995-2005: a Danish nationwide population-based study ', B M C Pulmonary Medicine, vol. 8, no. 1, pp. 24 . https://doi.org/10.1186/1471-2466-8-24
BMC Pulmonary Medicine
Kornum, J, Christensen, S, Grijota, M, Pedersen, L, Wogelius, P, Beiderbeck, A & Sørensen, H T 2008, ' The incidence of interstitial lung disease 1995-2005: a Danish nationwide population-based study ', B M C Pulmonary Medicine, vol. 8, no. 1, pp. 24 . https://doi.org/10.1186/1471-2466-8-24
Background Current data on incidence of interstitial lung diseases (ILDs) are sparse and concerns about an increasing trend have been raised. We examined incidence rates (IRs) of ILDs and changes in IRs between 1995 and 2005. Methods All persons with
Autor:
Lisbeth Nørum Pedersen, Henrik Toft Sørensen, Steffen Christensen, Jette Brommann Kornum, Annette B. Beiderbeck, Miriam Grijota
Publikováno v:
Christensen, S, Pedersen, L, Grijota, M, Kornum, J B, Beiderbeck, A & Sørensen, H T 2008, ' Incidence of interstitial pneumonitis among breast cancer patients: a 10-year Danish population-based cohort study. ', British Journal of Cancer, vol. 98, no. 11, pp. 1870-5 . https://doi.org/10.1038/sj.bjc.6604393
British Journal of Cancer
British Journal of Cancer
Udgivelsesdato: 2008-Jun-3 Chemotherapy and radiation therapy may increase risk for interstitial pneumonitis (IP) in breast cancer patients, but there are little current population-based data on IP incidence in these patients. We assessed population-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7fbbba5e6ba20103a859c6973d151d12
https://pure.au.dk/portal/da/publications/incidence-of-interstitial-pneumonitis-among-breast-cancer-patients-a-10year-danish-populationbased-cohort-study(8bad2290-3794-11dd-9465-000ea68e967b).html
https://pure.au.dk/portal/da/publications/incidence-of-interstitial-pneumonitis-among-breast-cancer-patients-a-10year-danish-populationbased-cohort-study(8bad2290-3794-11dd-9465-000ea68e967b).html
Autor:
Myrthe P P, Sukel, Nancy S, Breekveldt-Postma, Joëlle A, Erkens, Paul D, van der Linden, Annette B, Beiderbeck, Jan Willem W, Coebergh, Ron M C, Herings
Publikováno v:
Pharmacoepidemiology and drug safety. 17(2)
To assess the incidence of cardiovascular events among breast cancer patients after chemotherapy.Womenor =18 years with a breast tumour who received chemotherapy in 1992-2003 were selected from the PHARMO RLS. Chemotherapy with anthracyclines, a comb